Literature DB >> 20425289

The impact of depression in heart disease.

Yelizaveta Sher1, Sermsak Lolak, José R Maldonado.   

Abstract

Depression and heart disease affect millions of people worldwide. Studies have shown that depression is a significant risk factor for new heart disease and that it increases morbidity and mortality in established heart disease. Many hypothesized and studied mechanisms have linked depression and heart disease, including serotonergic pathway and platelet dysfunction, inflammation, autonomic nervous system and hypothalamic-pituitary-adrenal axis imbalance, and psychosocial factors. Although the treatment of depression in cardiac patients has been shown to be safe and modestly efficacious, it has yet to translate into reduced cardiovascular morbidity and mortality. Understanding the impact and mechanisms behind the association of depression and heart disease may allow for the development of treatments aimed at altering the devastating consequences caused by these comorbid illnesses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425289     DOI: 10.1007/s11920-010-0116-8

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  60 in total

1.  Genetic predictors of depressive symptoms in cardiac patients.

Authors:  Jeanne M McCaffery; Qing Ling Duan; Nancy Frasure-Smith; Amina Barhdadi; Francois Lespérance; Pierre Théroux; Guy A Rouleau; Marie-Pierre Dubé
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-04-05       Impact factor: 3.568

2.  Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial.

Authors:  François Lespérance; Nancy Frasure-Smith; Diana Koszycki; Marc-André Laliberté; Louis T van Zyl; Brian Baker; John Robert Swenson; Kayhan Ghatavi; Beth L Abramson; Paul Dorian; Marie-Claude Guertin
Journal:  JAMA       Date:  2007-01-24       Impact factor: 56.272

Review 3.  Depression in chronic heart failure: novel pathophysiological mechanisms and therapeutic approaches.

Authors:  John T Parissis; Katerina Fountoulaki; Ioannis Paraskevaidis; Dimitrios Kremastinos
Journal:  Expert Opin Investig Drugs       Date:  2005-05       Impact factor: 6.206

4.  Optimizing detection of major depression among patients with coronary artery disease using the patient health questionnaire: data from the heart and soul study.

Authors:  Brett D Thombs; Roy C Ziegelstein; Mary A Whooley
Journal:  J Gen Intern Med       Date:  2008-09-25       Impact factor: 5.128

Review 5.  Platelet function in patients with major depression.

Authors:  R C Ziegelstein; K Parakh; A Sakhuja; U Bhat
Journal:  Intern Med J       Date:  2008-08-16       Impact factor: 2.048

6.  Depression and five year survival following acute myocardial infarction: a prospective study.

Authors:  Robert M Carney; Kenneth E Freedland; Brian Steinmeyer; James A Blumenthal; Lisa F Berkman; Lana L Watkins; Susan M Czajkowski; Matthew M Burg; Allan S Jaffe
Journal:  J Affect Disord       Date:  2008-01-11       Impact factor: 4.839

7.  Negative illness perceptions are associated with new-onset depression following myocardial infarction.

Authors:  Chris Dickens; Linda McGowan; Carol Percival; Barbara Tomenson; Lawrence Cotter; Anthony Heagerty; Francis Creed
Journal:  Gen Hosp Psychiatry       Date:  2008-07-23       Impact factor: 3.238

8.  Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease.

Authors:  Nancy Frasure-Smith; François Lespérance
Journal:  Arch Gen Psychiatry       Date:  2008-01

9.  Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study.

Authors:  Louis T van Zyl; Francois Lespérance; Nancy Frasure-Smith; Alex I Malinin; Dan Atar; Marc-André Laliberté; Victor L Serebruany
Journal:  J Thromb Thrombolysis       Date:  2008-01-11       Impact factor: 2.300

10.  Depression increases risk of incident myocardial infarction among Veterans Administration patients with rheumatoid arthritis.

Authors:  Jeffrey F Scherrer; Katherine S Virgo; Angelique Zeringue; Kathleen K Bucholz; Theodore Jacob; Robert G Johnson; William R True; Robert M Carney; Kenneth E Freedland; Hong Xian; Liron Caplan; Jay McDonald; Seth A Eisen
Journal:  Gen Hosp Psychiatry       Date:  2009-05-09       Impact factor: 3.238

View more
  22 in total

1.  Depression or anxiety and all-cause mortality in adults with atrial fibrillation--A cohort study in Swedish primary care.

Authors:  Per Wändell; Axel C Carlsson; Danijela Gasevic; Lars Wahlström; Jan Sundquist; Kristina Sundquist
Journal:  Ann Med       Date:  2016-01-13       Impact factor: 4.709

2.  Effects of acute or repeated paroxetine and fluoxetine treatment on affective behavior in male and female adolescent rats.

Authors:  Leslie R Amodeo; Venuz Y Greenfield; Danielle E Humphrey; Veronica Varela; Joseph A Pipkin; Shannon E Eaton; Jelesa D Johnson; Christopher P Plant; Zachary R Harmony; Li Wang; Cynthia A Crawford
Journal:  Psychopharmacology (Berl)       Date:  2015-07-05       Impact factor: 4.530

3.  Racial discrimination, mood disorders, and cardiovascular disease among black americans.

Authors:  David H Chae; Amani M Nuru-Jeter; Karen D Lincoln; Kimberly R Jacob Arriola
Journal:  Ann Epidemiol       Date:  2011-11-21       Impact factor: 3.797

Review 4.  Does screening for depression in primary care improve outcome?

Authors:  Larry Culpepper
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

5.  Depression and human immunodeficiency virus infection are risk factors for incident heart failure among veterans: Veterans Aging Cohort Study.

Authors:  Jessica R White; Chung-Chou H Chang; Kaku A So-Armah; Jesse C Stewart; Samir K Gupta; Adeel A Butt; Cynthia L Gibert; David Rimland; Maria C Rodriguez-Barradas; David A Leaf; Roger J Bedimo; John S Gottdiener; Willem J Kop; Stephen S Gottlieb; Matthew J Budoff; Tasneem Khambaty; Hilary A Tindle; Amy C Justice; Matthew S Freiberg
Journal:  Circulation       Date:  2015-09-10       Impact factor: 29.690

Review 6.  Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients.

Authors:  Francisco J de Abajo
Journal:  Drugs Aging       Date:  2011-05-01       Impact factor: 3.923

7.  Secondary prevention: the ongoing challenge.

Authors:  Véronique L Roger
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2010-12-18

8.  Does the association between depressive symptoms and cardiovascular mortality risk vary by race? Evidence from the Health and Retirement Study.

Authors:  Benjamin D Capistrant; Paola Gilsanz; J Robin Moon; Anna Kosheleva; Kristen K Patton; M Maria Glymour
Journal:  Ethn Dis       Date:  2013       Impact factor: 1.847

Review 9.  Major depression can be prevented.

Authors:  Ricardo F Muñoz; William R Beardslee; Yan Leykin
Journal:  Am Psychol       Date:  2012 May-Jun

Review 10.  Of mice and men: modelling post-stroke depression experimentally.

Authors:  G Kronenberg; K Gertz; A Heinz; M Endres
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.